FPL64176
FPL64176 structure
|
Common Name | FPL64176 | ||
|---|---|---|---|---|
| CAS Number | 120934-96-5 | Molecular Weight | 347.40700 | |
| Density | 1.174g/cm3 | Boiling Point | 547.8ºC at 760mmHg | |
| Molecular Formula | C22H21NO3 | Melting Point | 144 - 145 °C | |
| MSDS | Chinese USA | Flash Point | 285.1ºC | |
Use of FPL64176FPL64176, a nondihydropyridine compound, is a potent agonist of L-type Ca2+ channels with an EC50 value of 16 nM[1][2]. |
| Name | fpl 64176 |
|---|---|
| Synonym | More Synonyms |
| Description | FPL64176, a nondihydropyridine compound, is a potent agonist of L-type Ca2+ channels with an EC50 value of 16 nM[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.174g/cm3 |
|---|---|
| Boiling Point | 547.8ºC at 760mmHg |
| Melting Point | 144 - 145 °C |
| Molecular Formula | C22H21NO3 |
| Molecular Weight | 347.40700 |
| Flash Point | 285.1ºC |
| Exact Mass | 347.15200 |
| PSA | 59.16000 |
| LogP | 4.23990 |
| Vapour Pressure | 4.72E-12mmHg at 25°C |
| Index of Refraction | 1.6 |
| Storage condition | 2-8°C |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
|
~86%
FPL64176 CAS#:120934-96-5 |
| Literature: Santiago, Braulio; Dalton, Christopher R.; Huber, Edward W.; Kane, John M. Journal of Organic Chemistry, 1995 , vol. 60, # 15 p. 4947 - 4950 |
|
~%
FPL64176 CAS#:120934-96-5 |
| Literature: Baxter; Dixon; Ince; Manners; Teague Journal of Medicinal Chemistry, 1993 , vol. 36, # 19 p. 2739 - 2744 |
|
~%
FPL64176 CAS#:120934-96-5 |
| Literature: Santiago, Braulio; Dalton, Christopher R.; Huber, Edward W.; Kane, John M. Journal of Organic Chemistry, 1995 , vol. 60, # 15 p. 4947 - 4950 |
|
~%
FPL64176 CAS#:120934-96-5 |
| Literature: Baxter; Fuher; Teague Synthesis, 1994 , # 2 p. 207 - 211 |
|
~%
FPL64176 CAS#:120934-96-5 |
| Literature: Baxter; Fuher; Teague Synthesis, 1994 , # 2 p. 207 - 211 |
|
~%
FPL64176 CAS#:120934-96-5 |
| Literature: Baxter; Fuher; Teague Synthesis, 1994 , # 2 p. 207 - 211 |
|
~%
FPL64176 CAS#:120934-96-5 |
| Literature: Baxter; Fuher; Teague Synthesis, 1994 , # 2 p. 207 - 211 |
|
~%
FPL64176 CAS#:120934-96-5 |
| Literature: Baxter; Dixon; Ince; Manners; Teague Journal of Medicinal Chemistry, 1993 , vol. 36, # 19 p. 2739 - 2744 |
|
~%
FPL64176 CAS#:120934-96-5 |
| Literature: Dalton, Christopher R.; Kane, John M.; Rampe, David Tetrahedron Letters, 1992 , vol. 33, # 39 p. 5713 - 5716 |
|
Metformin as adjunct antituberculosis therapy.
Sci. Transl. Med. 6(263) , 263ra159, (2014) The global burden of tuberculosis (TB) morbidity and mortality remains immense. A potential new approach to TB therapy is to augment protective host immune responses. We report that the antidiabetic d... |
|
|
A pharmacological model for calcium overload-induced tachycardia in isolated rat left atria.
Eur. J. Pharmacol. 576(1-3) , 122-31, (2007) Few experimental models produce spontaneous tachycardia in normal left atria to allow the study of the cellular mechanisms underlying this contributor to atrial fibrillation. We reported 2-aminoethoxy... |
|
|
Estrogen attenuates glutamate-induced cell death by inhibiting Ca2+ influx through L-type voltage-gated Ca2+ channels.
Brain Res. 1276 , 159-70, (2009) Estrogen-mediated neuroprotection is observed in neurodegenerative disease and neurotrauma models; however, determining a mechanism for these effects has been difficult. We propose that estrogen may l... |
| 2,5-Dimethyl-4-[2-(phenylmethyl)benzoyl]-1H-pyrrole-3-carboxlic acid methyl ester |
| MFCD00274043 |
| methyl 4-(2-benzylbenzoyl)-2,5-dimethyl-1H-pyrrole-3-carboxylate |